ストックスクリーナーアプリを入手
30.17
0.83%
0.19
前日終値:
$29.98
開ける：
$29.69
24時間の取引高:
388.67K
Relative Volume:
0.73
時価総額：
$1.11B
収益：
$154.15M
当期純損益:
$-33.58M
株価収益率:
-31.43
EPS:
-0.96
ネットキャッシュフロー:
$-20.74M
1週間 パフォーマンス:
+14.81%
1か月 パフォーマンス:
+17.01%
6か月 パフォーマンス:
-24.46%
1年 パフォーマンス:
+77.51%
1日の値動き範囲:
$29.20
$30.27
1週間の範囲:
$25.68
$30.27
52週間の値動き範囲:
$16.71
$59.23
Harrow Inc Stock (HROW) Company Profile
HROW を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
30.20 | 966.30M | 154.15M | -33.58M | -20.74M | -0.96 |
|
HLN
Haleon Plc Adr
|
11.08 | 50.54B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
170.93 | 74.02B | 9.29B | 2.52B | 2.28B | 5.57 |
|
RDHL
Redhill Biopharma Ltd Adr
|
1.8576 | 4.22M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.95 | 45.82B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.32 | 20.31B | 16.54B | -1.64B | 749.00M | -1.45 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-06 | 開始されました | H.C. Wainwright | Buy |
| 2024-12-04 | 繰り返されました | B. Riley Securities | Buy |
| 2024-04-11 | 開始されました | Craig Hallum | Buy |
| 2022-09-08 | 再開されました | B. Riley Securities | Buy |
| 2021-10-14 | 再開されました | B. Riley Securities | Buy |
| 2021-09-24 | 開始されました | Aegis Capital | Buy |
| 2021-07-02 | 開始されました | Ladenburg Thalmann | Buy |
すべてを表示
Harrow Inc (HROW) 最新ニュース
B. Riley Issues Pessimistic Forecast for Harrow Earnings - Defense World
Insiders Favor Harrow And 2 Other Leading Growth Companies - Yahoo Finance
Harrow Inc (HROW) Shares Up 4.04% on May 30 - GuruFocus
Obituary for Douglas "Doug" A. Harrow - Schaffer Funeral Home, Inc.
Harrow: Epic Growth & Operating Leverage On Full Display (NASDAQ:HROW) - Seeking Alpha
Harrow Inc (HROW) Stock Price Down 3.78% on May 22 - GuruFocus
Deutsche Bank AG Has $3.63 Million Holdings in Harrow, Inc. (NASDAQ:HROW) - Defense World
The Manufacturers Life Insurance Company Has $372,000 Holdings in Harrow, Inc. (NASDAQ:HROW) - Defense World
Harrow Inc (HROW) Stock Price Up 8.35% on May 16 - GuruFocus
Harrow Inc.: Opaleye management sells $150,055 in stock - Investing.com Australia
Harrow Inc.: Opaleye management sells $150,055 in stock By Investing.com - Investing.com India
Jim Cramer on Harrow, Inc. (HROW) – “Eye Care’s a Good Biz – If It Makes Money, Don’t Walk Away Pre-Breakout” - Insider Monkey
Harrow to Present at Two Investor Conferences in May - Business Wire
Jim Cramer Is 'OK' With Harrow, Recommends Buying This Energy Stock - Benzinga
Harrow Health, Inc. (NASDAQ:HROW) Q1 2025 Earnings Call Transcript - Insider Monkey
Harrow (HROW) Faces Price Target Cut Amid Q1 Earnings Miss | HRO - GuruFocus
HROW Stock Price Target Raised to $60 by Analyst | HROW Stock Ne - GuruFocus
Price T Rowe Associates Inc. MD Buys 1,428 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World
Harrow (NASDAQ:HROW) Price Target Raised to $60.00 at HC Wainwright - Defense World
Where Harrow Stands With Analysts - Benzinga
HROW Stock Update: Analyst Raises Price Target to $60 | HROW Sto - GuruFocus
HROW Stock Price Target Raised to $60 by Analyst | HROW Stock News - GuruFocus
Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates - MSN
Harrow Inc (HROW) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... - Yahoo Finance
Harrow Inc (HROW) Q1 2025 Earnings Call Highlights: Record Reven - GuruFocus
Harrow Inc (HROW) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... By GuruFocus - Investing.com Canada
Harrow Health Reports Strong Q1 2025 Revenue Growth - TipRanks
Harrow Announces First-Quarter 2025 Financial Results - BioSpace
Transcript : Harrow, Inc., Q1 2025 Earnings Call, May 09, 2025 - marketscreener.com
Harrow Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Harrow: Q1 Earnings Snapshot - CT Insider
Harrow Health Q1 2025 slides: revenue up 43% as ophthalmic portfolio expands - Investing.com
Harrow Health (HROW) Reports Q1 Revenue Miss Despite Growth - GuruFocus
Harrow Inc (HROW) Q1 2025 Earnings: EPS of -$0.50 Misses Estimate, Revenue at $47.8M Below Forecast - GuruFocus
Earnings Flash (HROW) HARROW INC. Reports Q1 Loss $0.38 Per Share - marketscreener.com
Harrow (HROW) Sees Promising Revenue Growth and Expansion Plans | HROW Stock News - GuruFocus
HROW Forecasts Surpassing $280 Million Revenue by 2025 | HROW St - GuruFocus
HROW Forecasts Surpassing $280 Million Revenue by 2025 | HROW Stock News - GuruFocus
Harrow Inc (HROW) Q1 2025 Earnings Report Preview: What to Look For - GuruFocus
Harrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025 | HROW Stock News - GuruFocus
Examining the Future: Harrow's Earnings Outlook - Nasdaq
What To Expect From Harrow Inc (HROW) Q1 2025 Earnings - Yahoo Finance
Harrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025 - Business Wire
Invesco Ltd. Lowers Position in Harrow, Inc. (NASDAQ:HROW) - Defense World
Harrow, Inc. (NASDAQ:HROW) Shares Sold by Wells Fargo & Company MN - Defense World
Harrow Inc (HROW) 財務データ
収益
当期純利益
現金流量
EPS
Harrow Inc (HROW) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
May 13 '25 |
Sale |
26.59 |
5,000 |
132,945 |
125,000 |
| BOLL ANDREW R. | Chief Financial Officer |
Apr 03 '25 |
Option Exercise |
0.00 |
346,500 |
0 |
914,589 |
| SAHAREK JOHN P. | CEO & President, ImprimisRx |
Apr 03 '25 |
Option Exercise |
0.00 |
277,200 |
0 |
576,863 |
| BAUM MARK L | Chief Executive Officer |
Apr 03 '25 |
Option Exercise |
0.00 |
762,300 |
0 |
2,899,825 |
| Opaleye Management Inc. | 10% Owner |
Mar 18 '25 |
Sale |
30.01 |
5,000 |
150,055 |
140,000 |
| Opaleye Management Inc. | 10% Owner |
Mar 18 '25 |
Sale |
29.64 |
5,000 |
148,200 |
145,000 |
| Opaleye Management Inc. | 10% Owner |
Feb 28 '25 |
Sale |
28.05 |
5,000 |
140,250 |
150,000 |
| Opaleye Management Inc. | 10% Owner |
Jan 22 '25 |
Sale |
35.59 |
20,000 |
711,814 |
155,000 |
| SAHAREK JOHN P. | CEO of ImprimisRx |
Sep 11 '24 |
Option Exercise |
7.37 |
90,000 |
663,300 |
344,803 |
3.28%
2.99%
大文字化:
|
ボリューム (24 時間):